» Articles » PMID: 18754678

The Relative Binding Affinities of PDZ Partners for CFTR: a Biochemical Basis for Efficient Endocytic Recycling

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2008 Aug 30
PMID 18754678
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial chloride channel mutated in patients with cystic fibrosis. Its expression and functional interactions in the apical membrane are regulated by several PDZ (PSD-95, discs large, zonula occludens-1) proteins, which mediate protein-protein interactions, typically by binding C-terminal recognition motifs. In particular, the CFTR-associated ligand (CAL) limits cell-surface levels of the most common disease-associated mutant DeltaF508-CFTR. CAL also mediates degradation of wild-type CFTR, targeting it to lysosomes following endocytosis. Nevertheless, wild-type CFTR survives numerous cycles of uptake and recycling. In doing so, how does it repeatedly avoid CAL-mediated degradation? One mechanism may involve competition between CAL and other PDZ proteins including Na (+)/H (+) exchanger-3 regulatory factors 1 and 2 (NHERF1 and NHERF2), which functionally stabilize cell-surface CFTR. Thus, to understand the biochemical basis of WT-CFTR persistence, we need to know the relative affinities of these partners. However, no quantitative binding data are available for CAL or the individual NHERF2 PDZ domains, and published estimates for the NHERF1 PDZ domains conflict. Here we demonstrate that the affinity of the CAL PDZ domain for the CFTR C-terminus is much weaker than those of NHERF1 and NHERF2 domains, enabling wild-type CFTR to avoid premature entrapment in the lysosomal pathway. At the same time, CAL's affinity is evidently sufficient to capture and degrade more rapidly cycling mutants, such as DeltaF508-CFTR. The relatively weak affinity of the CAL:CFTR interaction may provide a pharmacological window for stabilizing rescued DeltaF508-CFTR in patients with cystic fibrosis.

Citing Articles

The conformation of the nSrc specificity-determining loop in the Src SH3 domain is modulated by a WX conserved sequence motif found in SH3 domains.

Longshore-Neate F, Ceravolo C, Masuga C, Tahti E, Blount J, Smith S Front Mol Biosci. 2024; 11:1487276.

PMID: 39698111 PMC: 11653366. DOI: 10.3389/fmolb.2024.1487276.


Cell type-specific regulation of CFTR trafficking-on the verge of progress.

Farinha C, Santos L, Ferreira J Front Cell Dev Biol. 2024; 12:1338892.

PMID: 38505263 PMC: 10949533. DOI: 10.3389/fcell.2024.1338892.


It Takes Two to Tango! Protein-Protein Interactions behind cAMP-Mediated CFTR Regulation.

Murabito A, Bhatt J, Ghigo A Int J Mol Sci. 2023; 24(13).

PMID: 37445715 PMC: 10341646. DOI: 10.3390/ijms241310538.


High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display.

Li A, Voleti R, Lee M, Gagoski D, Shah N Elife. 2023; 12.

PMID: 36927728 PMC: 10065799. DOI: 10.7554/eLife.82345.


Additive energetic contributions of multiple peptide positions determine the relative promiscuity of viral and human sequences for PDZ domain targets.

Tahti E, Blount J, Jackson S, Gao M, Gill N, Smith S Protein Sci. 2023; 32(4):e4611.

PMID: 36851847 PMC: 10022582. DOI: 10.1002/pro.4611.


References
1.
Li J, Chen C, Liu-Chen L . Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate. J Biol Chem. 2002; 277(30):27545-52. DOI: 10.1074/jbc.M200058200. View

2.
Cheng J, Wang H, Guggino W . Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL. J Biol Chem. 2003; 279(3):1892-8. DOI: 10.1074/jbc.M308640200. View

3.
Schuck P . Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. Curr Opin Biotechnol. 1997; 8(4):498-502. DOI: 10.1016/s0958-1669(97)80074-2. View

4.
Cheng J, Moyer B, Milewski M, Loffing J, Ikeda M, Mickle J . A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem. 2001; 277(5):3520-9. DOI: 10.1074/jbc.M110177200. View

5.
Cheng S, Gregory R, Marshall J, Paul S, Souza D, White G . Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990; 63(4):827-34. DOI: 10.1016/0092-8674(90)90148-8. View